Analytical diagnosing of milnacipran poisonings
DOI:
https://doi.org/10.24959/cphj.16.1380Keywords:
chemico-toxicological analysis, mіlnacipran, isolation from the biological material, TLC-screening, high pressure liquid chromatographyAbstract
The method of milnacipran isolation with chloroform from the dehydrated biological material with subsequent extraction purification in the n-hexane-acetonitrile solvent system has been developed. The method developed has allowed to isolate 47±5% of the antidepressant. The TLC-screening method of a number of antidepressants has been developed using four mobile phases with a low correlation and the sequential scheme of visualization by a set of chromogenic reagents. It has allowed to separate milnacipran, venlafaxine, amitriptyline, fluoxetine and sertraline. As differentiating reagents the Liebermann’s reagent and the Mandelin’s reagent in modification consisting in sequential treatment of the sample by the Mandelin’s reagent and formaldehyde vapours have been suggested. The methods of identification and quantitative determination of milnacipran in the biological material after the TLC purification using HPLC with multiwave UV-spectrophotometric detection have been developed. The calibration curve of the dependence of the peak area on the concentration was described by the following equation: Y=5.14·10-5X; linearity was within the concentration range of 24.2-500 µg/ml; LOD and LOQ were 8.0 and 24.2 µg/ml (at 262 nm), respectively. The results obtained can be used in forensic toxicology for diagnosing milnacipran poisonings.
References
Баюрка С.В., Бондар В.С., Карпушина С.А. // Вісник фармації. – 2009. – №3 (59). – С. 23-26.
Баюрка С.В., Карпушина С.А., Мороз В. П. // Фармация. – 2015. – №2. – С. 7-9.
Фурсов Б.Б. // Психические расстройства в общей медицине. – 2009. – №2. – C. 63-65.
Baiurka S., Karpushina S. // J. Chem. Pharm. Res. – 2013. – Vol. 5 (12). – P. 1110-1120.
Castaing N., Titier K., Receveur-Daurel M. et al. // J. Anal. Toxicol. – 2007. – Vol. 31 (6). – P. 334-341.
Clarke’s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material: 4-th ed. / A.C.Moffat, M.D.Osselton, B.Widdop et al. – London, Chicago: Pharmaceutical Press, 2011. – 2736 p.
Dallet P., Labat L., Richard M. et al. // J. Liq. Chromatogr. Relat. Technol. – 2002. – Vol. 25 (1). – P. 101-111.
Fanton L., Bévalot F., Grait H. et al. // J. Forensic Leg. Med. – 2008. – Vol. 15 (6). – P. 388-390.
Rop P.P., Sournac M.H., Burle J. et al. // J. Anal. Toxicol. – 2002. – Vol. 26 (2). – P. 123-126.
Flanagan R.J. // Hum. Psychopharmacol. – 2008. – Vol. 23 (Suppl. 1). – P. 43-51.
SOFT / AAFS Forensic Laboratory Guidelines. – 2006. – 1-24 p.
Titier K., Castaing N., Scotto-Gomez E. et al. // Ther. Drug Monit. – 2003. – Vol. 25 (5). – P. 581-587.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
